Hubei Guangji Pharmaceutical Co Ltd
SZSE:000952

Watchlist Manager
Hubei Guangji Pharmaceutical Co Ltd Logo
Hubei Guangji Pharmaceutical Co Ltd
SZSE:000952
Watchlist
Price: 7.67 CNY 1.46% Market Closed
Market Cap: ¥2.7B

Wall Street
Price Targets

Price Targets Summary
Hubei Guangji Pharmaceutical Co Ltd

There are no price targets for Hubei Guangji Pharmaceutical Co Ltd.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Hubei Guangji Pharmaceutical Co Ltd Competitors:
Price Targets
ISN
Intershop Holding AG
-1% Downside
THRY
Thryv Holdings Inc
165% Upside

Revenue
Forecast

3% / Year
Past Growth
3% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
3% / Year
Past Growth
3% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

For the last 13 years the compound annual growth rate for Hubei Guangji Pharmaceutical Co Ltd's revenue is 3%. The projected CAGR for the next 8 years is 3%.

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Hubei Guangji Pharmaceutical Co Ltd's stock price target?
Not Available

Hubei Guangji Pharmaceutical Co Ltd doesn't have any price targets made by Wall Street professionals.

What is Hubei Guangji Pharmaceutical Co Ltd's Revenue forecast?
Projected CAGR
3%

For the last 13 years the compound annual growth rate for Hubei Guangji Pharmaceutical Co Ltd's revenue is 3%. The projected CAGR for the next 8 years is 3%.

Back to Top